Jack Phillips - Jun 22, 2022 Form 4 Insider Report for Accelerate Diagnostics, Inc (AXDX)

Role: Chief Executive Officer
Signature: /s/ Steven Reichling, attorney-in-fact
Stock symbol: AXDX
Transactions as of: Jun 22, 2022
Transactions value $: -$25,660
Form type: 4
Date filed: 6/24/2022, 04:14 PM
Previous filing: Apr 28, 2022
Next filing: Jan 17, 2023

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	AXDX	Common Stock	Options Exercise	$0	+62.2K	+29.87%	$0.00	270K	Jun 22, 2022	Direct	F1
transaction	AXDX	Common Stock	Sale	-$25.7K	-28.2K	-10.43%	$0.91	242K	Jun 22, 2022	Direct	F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	AXDX	Employee Restricted Stock Units	Options Exercise	$0	-62.2K	-50%	$0.00	62.2K	Jun 22, 2022	Common Stock	62.2K		Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of RSUs. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the Reporting Person.
F2	The reporting person received restricted stock units, of which vests in equal annual amounts on each anniversary of the grant date over three years, beginning on June 22, 2021 and ending on June 22, 2023. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested.